World Asthma Day 2024 - Asthma Education Empowers

World Asthma Day 2024 - Respiratory Research

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Despite strides in therapeutic development for asthma management, its morbidity and mortality persistently rise, particularly burdening low- and middle-income countries. To address this pressing need for deeper insight into asthma pathogenesis and therapeutic targets, Respiratory Research presents two focused issues that showcase cutting-edge discoveries in the field.  The findings presented in both collections, “Asthma: Towards a Cure” and “Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease” will provide exciting discoveries furthering education and speaking to the theme of this year’s World Asthma Day – Asthma Education Empowers.

The first themed collection, "Asthma: Towards a Cure," compiles manuscripts delving into innovative science aimed at addressing the unmet challenge of managing and ultimately curing asthma. Within this collection, authors unveil novel biomarkers predicting therapeutic responses to both emerging and established treatments. Encompassing fundamental, translational, and clinical studies, these manuscripts not only disseminate new approaches but also strive to influence clinical practice and policy.

The second issue, "Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease,” spotlights the utility of an experimental platform mirroring the complexities of the in vivo lung environment. While precision cut lung slices (PCLS) have been utilized in respiratory research since the late 1970s, recent innovations have propelled their acceptance and expanded their applications across various domains. From toxicology and drug discovery to lung cancer biology and respiratory pathogen exposure, PCLS derived from both animal models and human lungs have significantly enhanced our understanding of integrated cellular responses, elucidating fundamental mechanisms in lung biology and providing a platform for therapeutic discovery.

Given the global impact of asthma, Respiratory Research is committed to sharing breakthroughs in asthma research, thereby contributing to the advancement of global health initiatives and providing education to both the scientific community and the general public to empower everyone to combat this disease.


Cynthia Koziol-White and Reynold A. Panettieri, Jr.

Rutgers University, New Brunswick, New Jersey USA

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Life Sciences > Health Sciences > Clinical Medicine > Diseases > Respiratory Tract Diseases > Asthma

Related Collections

With collections, you can get published faster and increase your visibility.

Asthma: Towards a Cure

RR seeks manuscripts that address cutting-edge science addressing the unmet need to manage and cure asthma. Such manuscripts could include novel biomarkers that predict therapeutic responses to novel or current therapy. Fundamental, translational, and clinical studies are encouraged that can promote the dissemination and implementation of novel approaches to change clinical practice and policy.

Publishing Model: Open Access

Deadline: Ongoing

Pulmonary fibrosis: new insights

The field of pulmonary fibrosis has gone through substantial changes in recent years, with several traditional views on disease pathogenesis and treatment being challenged and replaced by more convincing concepts. The collection seeks manuscripts that address the diagnosis, characterization and management of pulmonary fibrosis, with emphasis on novel concepts of disease pathogenesis, predictors of disease behavior and response to treatment and developmental drugs.

Publishing Model: Open Access

Deadline: Ongoing